ViroCell Biologics Retroviral & Lentiviral Vector CDMO
Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing
Notes from the Inside Viral Vector Science Videos + Webinars Articles
In the News Press Releases Conferences
Careers
Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles
ViroCell Biologics Retroviral & Lentiviral Vector CDMO
News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us

Virocell and Great Ormond Street Hospital team up to tackle viral vector shortage

MORE
In the NewsFlorence BuchananOctober 25, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy, Life Sciences Review, UK CDMO, ViroCell, Great Ormond Street Hospital, John W. Hadden II, Farzin Farzaneh, Matthew Shaw
LinkedIn0 0 Likes
Previous

Gene therapy ‘factory’ to save children

In the NewsFlorence BuchananJanuary 29, 2022Virocell BiologicsGOSH, CDMO, Gene and cell therapies, viral vector, cell therapy, gene therapy, The Times, UK CDMO, Great Ormond Street Hospital, ViroCell, John W. Hadden II, Farzin Farzaneh, biotech, Dame Kate Bingham, John Hadden, Rhys Evans, SCID, severe combined immunodeficiency, Professor Claire Booth, leukaemia, spinal muscular atrophy, Leber congenital amaurosis, inherited diseases
Next

Virocell and Great Ormond Street Hospital team up to tackle viral vector shortage

In the NewsFlorence BuchananOctober 11, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy, European Pharmaceutical Manufacturer, UK CDMO, ViroCell, Matthew Shaw, CEO at Great Ormond Street Hospital
 

Webinar Sept 3

Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design
08:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST

REGISTER HERE

Team ViroCell will be on the road

2-4 Sept – Advanced Therapies Week Europe Barcelona

23-26 Sept – CAR-TCR Summit US Boston

6-8 October – ESGCT Seville

18-19 Nov – Advanced Therapies Congress US Philadelphia

1-3 Dec – CGT International Europe Berlin

6-9 Dec – ASH Annual Meeting and Exposition Orlando

 

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch
videosNewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2025 ViroCell Biologics, Ltd. All rights reserved.